SCCM Pod-400 Are AKI Biomarkers Ready for Clinical Use?
Kyle B. Enfield, MD, FCCM, and Azra Bihorac, MD, MS, FCCM, discuss best practices and complexities of implementing biomarkers for kidney stress and acute kidney injury (AKI) and what the future holds for AKI biomarker literature.
AKI, Biomarkers, Stress
SCCM Pod-405 Acute Kidney Injury Biomarkers and the Challenges of Clinical Use
Ludwig H. Lin, MD, and Michael G.S. Shashaty, MD, MS, discuss acute kidney injury (AKI) biomarkers and whether they are ready for clinical use.